In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococi, enterococci and Clostridium difficile
- 1 November 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 26 (5), 627-628
- https://doi.org/10.1093/jac/26.5.627
Abstract
The minimum inhibitory concentrations (MICs) of different antibiotics were determined by a broth microdilution method for staphylococci, enterococci and Clostridium difficile. The antimicrobial agents tested were vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873, rifampicin and piperacillin, the latter limited to enterococci. In terms of MIC90s, daptomycin (0.89 mg/l), MDL 62873 (0.99 mg/l), and teicoplanin (1.50 mg/l) were found to be highly active against methicillin-resistant Staphylococcus aweus (MRSA). Daptomycin (MIC90 0.48 mg/l), MDL 62873 (0.95 mg/l) and ramoplanin (1.45 mg/l) were the most active drugs against methicillinresistant S.epidermidis (MRSE). Teicoplanin (MIC90, 0.45 mg/l) was the most active agent against enterococci, followed by MDL 62873 (0.65 mg/l) and daptomycin (1.60 mg/;). MDL 62873 gave the lowest MIC90, (0.17 mg/l) for C. difficile. Teicoplanin (MIC90, 0.42 mg/l), daptomycin (0.87 mg/l) and ramoplanin (0.98 mg/l) were also very active. Our results indicate that teicoplanin, daptomycin, ramoplanin and MDL 62873, a teicoplanin derivative, are potentially effective alternative antibiotics for treatment of infections caused by staphylococd, entero-cocd and C. difficile.Keywords
This publication has 8 references indexed in Scilit:
- Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1989
- Inducible, transferable resistance to vancomycin in Enterococcus faecium, D399Journal of Antimicrobial Chemotherapy, 1989
- Vancomycin-resistant gram-positive bacteria isolated from human sourcesJournal of Clinical Microbiology, 1988
- In vitro activity of LY146032 alone and in combination with other antibiotics against gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1988
- In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibioticAntimicrobial Agents and Chemotherapy, 1986
- In vitro activity of teichomycin and vancomycin alone and in combination with rifampinAntimicrobial Agents and Chemotherapy, 1983
- International Recognition of Methicillin-Resistant Strains of Staphylococcus aureusAnnals of Internal Medicine, 1982
- ORAL VANCOMYCIN FOR ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITISThe Lancet, 1978